Medical Research Stocks on Investors' Radar -- China Cord Blood, VWR Corp., Quest Diagnostics, and LabCorp
29 Aug, 2017, 07:05 ET
NEW YORK, August 29, 2017 /PRNewswire/ --
If you want a Stock Review on CO, VWR, DGX, or LH then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Monday, August 28, 2017, US markets saw four out of nine sectors finishing the day in red, 2 in green, and 3 in neutral territory. Major US indices were also mixed at the close of yesterday's session. The NASDAQ Composite ended the day at 6,283.02, up 0.28%; the Dow Jones Industrial Average edged 0.02% lower, to finish at 21,808.40; and the S&P 500 closed at 2,444.24, up 0.05%. This Tuesday morning, DailyStockTracker.com looks at the performance of these four Medical Laboratories & Research stocks: China Cord Blood Corp. (NYSE: CO), VWR Corp. (NASDAQ: VWR), Quest Diagnostics Inc. (NYSE: DGX), and Laboratory Corp. of America Holdings (NYSE: LH). This morning's free research reports on the aforesaid equities can be accessed upon registration on DailyStockTracker.com at:
China Cord Blood
On Monday, shares in Central, Hong Kong-based China Cord Blood Corp. recorded a trading volume of 736,541 shares, which was above their three months average volume of 619.89 thousand shares. The stock ended the session 8.04% lower at $13.49. The Company's shares have gained 13.27% in the last month, 53.47% over the previous three months, 155.01% in the past twelve months, and 120.42% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 23.18% and 80.39%, respectively. Moreover, shares of China Cord Blood, which together with its subsidiaries, provide umbilical cord blood storage and ancillary services in the People's Republic of China, have a Relative Strength Index (RSI) of 62.43. Visit us today and download your complete report on CO for free at:
Radnor, Pennsylvania-based VWR Corp.'s stock closed the day 0.24% lower at $33.00 with a total trading volume of 457,210 shares. The Company's shares have advanced 17.98% over the last twelve months and 31.84% since the start of this year. The stock is trading above its 50-day and 200-day moving averages by 0.02% and 12.93%, respectively. Additionally, shares of VWR Corp. , which together with its subsidiaries, operates as an independent provider of laboratory products, services, and solutions to the life science, general research, and applied markets, have an RSI of 50.80. The complimentary research report on VWR can be accessed at:
Shares in Madison, New Jersey headquartered Quest Diagnostics Inc. recorded a trading volume of 912,688 shares, which was above their three months average volume of 810.91 thousand shares. The stock ended yesterday's trading session 0.02% higher at $107.04. The stock is trading above its 200-day moving average by 7.17%. Furthermore, shares of Quest Diagnostics, which provides diagnostic testing information and services in the US and internationally, have an RSI of 48.49. Register for free on DailyStockTracker.com and download the research report on DGX at:
Laboratory Corp. of America
Burlington, North Carolina headquartered Laboratory Corp. of America Holdings' (LabCorp) stock finished Monday's session 1.00% lower at $153.22 with a total trading volume of 654,461 shares. The Company's shares have advanced 10.61% over the previous three months, 12.63% in the past twelve months, and 19.35% since the start of this year. The stock is trading above its 200-day moving average by 8.80%. Additionally, shares of LabCorp, which operates as an independent clinical laboratory company worldwide, have an RSI of 40.94. Get free access to your research report on LH at:
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected]. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: [email protected]
Phone number: (207)331-3313
Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
Share this article